British cost agency to take broader view of drug value
March 26, 2014 at 20:01 PM EDT
LONDON, March 27 (Reuters) - British healthcare cost agency NICE is to take a broader view of the value offered by new medicines under proposals that may make it more likely that it will say "yes" to novel drugs in future.
